The board of China’s Renhe Pharmaceuticals Co., Ltd. agreed to develop a broad-based industrial hemp project and three other initiatives in the medical sector. Projects approved by the board in a meeting last week included the Renhe Xianghe Industrial Hemp Comprehensive Utilization Industry Project, upgrades for a project in traditional Chinese medicines, development of a smart medicines logistics park, and construction of an R&D center. The total investment for the four projects is 71,279,500 yuan (~€9 million/$~10.5), which was raised in a non-public stock offering earlier this year.
Like HempToday? How you can support us
Your donations help us to keep HempToday open for all readers, regardless of what they can afford to pay. Through this “information equality” we're able to support hemp entrepreneurs and stakeholders all over the world by keeping a spotlight on hemp and all the promise it offers for economic development and healing our planet.